MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    Diagnostic accuracy of CSF tap test parameters in Normal pressure hydrocephalus: An ambispective cohort study

    A. Elavarasi, S. Poudel, M. Tripathi, N. Wig, A. Srivastava, S. Kale, A. Suri, S. P, A. Garg, R. Rajan, D. Radhakrishnan, R. Singh (New Delhi, India)

    Objective: To study the sensitivity and specificity of CSF tap test in predicting outcomes following shunt surgery Background: Idiopathic Normal pressure hydrocephalus (iNPH) is a…
  • 2025 International Congress

    Clinical and Pathological Features of CSF1R-Related Disorder Associated with the c.2330G>A, p.R777Q Pathogenic Variant

    T. Chmiela, A. Strongosky, D. Dickson, Z. Wszolek (Katowice, Poland)

    Objective: To report the clinical and pathological features of CSF1R-RD associated with the c.2330G>A, p.R777Q variant, and to report a new family carrying this variant.…
  • 2025 International Congress

    Clinical and Genetic Characteristics of PLA2G6-parkinsonism in Southwest China and a Comprehensive Literature Review

    YF. Cheng, HF. Shang (Chengdu, China)

    Objective: To comprehensively characterize the clinical, imaging and genetic features of PLA2G6-related parkinsonism. Background: Biallelic PLA2G6 mutations are associated with early-onset autosomal recessive parkinsonism, exhibiting a…
  • 2025 International Congress

    Neuroprotective efficacy of EDTA against manganese neurotoxicity: Implications for modulating Parkinsonian syndromes

    H. Harifi, H. Hami, L. Bikjdaouene (Kenitra, Morocco)

    Objective: This study investigates the neuroprotective potential of ethylenediaminetetraacetic acid (EDTA) in reducing the neurotoxic effects of manganese (Mn), focusing on both motor and non-motor…
  • 2025 International Congress

    Phenotypic Spectrum In Children And Adolescents With Glucose Transporter 1 Deficiency A Multicentric Retrospective Study

    S. Yoganathan, C. Pefaur, V. Gowda, V. Cornejo, V. Quiroz, P. Jain, S. Sharma, L. Guilder, G. Costain, I. Tein, C. Gorodetksy (Toronto, Canada)

    Objective: To describe the spectrum of phenotypes in children and adolescents with biochemically and/or genetically proven Glucose Transporter 1 (GLUT1) deficiency. Background: The phenotypes in…
  • 2025 International Congress

    PARKinSOUND 2.0: The Impact of Orchestra Participation on Patients with Parkinson’s Disease

    S. Lopes, A. Ferreira, S. Gomes, C. Morgado, L. Costa, A. Goios, J. Ferreira, M. Rodrigues (Braga, Portugal)

    Objective: This study evaluates the impact of participation in a community orchestra on people with PD. Background: As interest in non-pharmacological therapies for Parkinson’s disease…
  • 2025 International Congress

    Anti-Parkinsonian effects of Globimetula cupulata leaf extract and its underlying mechanisms in 6-hydroxydopamine-lesioned rat model

    A. Hamadjida, R. Ayissi Mbomo, S. Minko, F. Ntchapda, J. Mingoas Kilekoung (BERTOUA, Cameroon)

    Objective: To evaluate the neuroprotective effects of Globimetula cupulata in a rat model of Parkinson Disease (PD) induced by 6-hydroxydopamine (6-OHDA) injection in the striatum,…
  • 2025 International Congress

    Co-Occurrence of DAT Scan, Amyloid PET Scan, and Alzheimer’s Genetic Screening Abnormalities in Patient with Early-Onset Neurocognitive Decline: A Case Report

    A. Mason, R. Payne, N. Shneyder, E. Baldinger (Tampa, USA)

    Objective: The presented case report aims to show the possible overlap between causes of neurocognitive decline and the importance of considering comorbidities when discussing anti-amyloid monoclonal…
  • 2025 International Congress

    Clinical Characteristics of Parkinsons Disease and their Role in Differential Diagnosis

    M. Ganieva, L. Tolibova (Dushanbe, Tajikistan)

    Objective: To study and systematize the clinical characteristics of Parkinson's disease (PD) and their role in differential diagnosis with other parkinsonian syndromes. Background: Parkinson’s disease…
  • 2025 International Congress

    Efficacy and Safety of Fecal Microbiota Transplantation in the Management of Parkinson’s Disease: A Systematic Review

    Y. Abdalla, A. Hassan (Zagazig, Egypt)

    Objective: 1. Assess the efficacy of FMT in PD by evaluating its impact on motor and non-motor symptoms.2. Determine the safety profile of FMT in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley